IP Library Granted Patent US 7,473,422
Granted Patent B2
US 7,473,422 · App. 10/855,595 · Granted Jan 6, 2009

Antibodies to retinoid metabolizing protein

Assignee: Queen's University at Kingston
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,473,422
App. No.
10/855,595
Granted
Jan 6, 2009
Kind
B2
Abstract

Amino acid sequences and corresponding nucleic acid sequence of retinoid metabolizing protein found in human, mouse and zebrafish are described, as well as methods of using same.

Claims (16)

1. An isolated antibody or antigen-binding fragment thereof which specifically binds to a protein having the sequence identified as SEQ ID NO:4.

2. An isolated antibody or antigen-binding fragment thereof which specifically binds to a protein having the sequence identified as SEQ ID NO:2.

3. An isolated antibody or antigen-binding fragment thereof which specifically binds to a protein having the sequence identified as SEQ ID NO:32.

4. The antibody or antigen-binding fragment thereof according to claim 1 , 2 or 3 , wherein the antibody or antibody fragment is a monoclonal antibody or a fragment of a monoclonal antibody.

5. The antibody or antigen-binding fragment thereof according to claim 1 , 2 or 3 , wherein the antibody or antibody fragment does not bind only to a heme-binding motif of the protein corresponding to amino acid residues from about 431 to about 449 of SEQ ID NO: 2, or only to a heme-binding motif of the protein corresponding to amino acid residues from about 435 to about 453 of SEQ ID NO: 4, or only to a heme-binding motif of the protein corresponding to amino acid residues from about 435 to about 453 of SEQ ID NO: 32.

6. The antibody or antigen-binding fragment thereof according to claim 5 , wherein the antibody or antibody fragment is a monoclonal antibody or a fragment of a monoclonal antibody.

7. An isolated antibody or antigen-binding fragment thereof which specifically binds to an epitope located within the region consisting of amino acids 1 to 432 of SEQ ID NO:2.

8. The antibody or antigen-binding fragment thereof according to claim 7 , wherein the epitope comprises amino acids 70 to 74 of SEQ ID NO: 2.

9. An isolated antibody or antigen-binding fragment thereof which specifically binds to an epitope located within the region consisting of amino acids 1 to 436 of SEQ ID NO:4.

10. The antibody or antigen-binding fragment thereof according to claim 9 , wherein the epitope comprises amino acids 70 to 74 of SEQ ID NO:4.

11. An isolated antibody or antigen-binding fragment thereof which specifically binds to an epitope located within the region consisting of amino acids 1 to 436 of SEQ ID NO:32.

12. The antibody or antigen-binding fragment thereof according to claim 11 , wherein the epitope comprises amino acids 70 to 74 of SEQ ID NO:32.

13. A kit for determining the presence of a protein which oxidizes a retinoid, comprising an antibody or antigen-binding fragment of claim 1 , 2 or 3 linked to a reporter system, wherein the reporter system produces a detectable response when a predetermined amount of the protein and the antibody or antigen-binding fragment are bound together.

14. The kit according to claim 13 , wherein the antibody or antigen-binding fragment is a monoclonal antibody or a fragment of a monoclonal antibody.

15. A kit for determining the presence of a protein which oxidizes a retinoid, comprising an antibody or antigen-binding fragment of claim 5 linked to a reporter system, wherein the reporter system produces a detectable response when a predetermined amount of the protein and the antibody or antigen-binding fragment are bound together.

16. The kit according to claim 15 , wherein the antibody or antigen-binding fragment is a monoclonal antibody or a fragment of a monoclonal antibody.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2012
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: CYTOCHROMA, INC.; CYTOCHROMA HOLDINGS ULC; PROVENTIV THERAPEUTICS, LLC
Reel/Frame 028881/0338 →
SECURITY AGREEMENT Recorded Sep 28, 2010
From: CYTOCHROMA INC.; PROVENTIV THERAPEUTICS, LLC; CYTOCHROMA HOLDINGS ULC
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 025051/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2006
From: JONES, GLENVILLE; WHITE, JAY A.; BECKETT, BARBARA R.; PETKOVICH, P. MARTIN
To: QUEEN'S UNIVERSITY AT KINGSTON
Reel/Frame 017233/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2006
From: JONES, GLENVILLE; PETKOVICH, P. MARTIN; WHITE, JAY A.; BECKETT, BARBARA R.
To: QUEEN'S UNIVERSITY AT KINGSTON
Reel/Frame 017233/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2005
From: PETKOVICH, P. MARTIN; WHITE, JAY A.; BECKETT, BARBARA R.; JONES, GLENVILLE
To: QUEEN'S UNIVERSITY AT KINGSTON
Reel/Frame 015923/0909 →
Continuity (7)
Division 0966848200 · Sep 25, 2000
Division 0888216400 · Jun 25, 1997
Continuation In Part PCTCA970044000 · Jun 23, 1997
Continuation In Part 1085559500
Continuation 0872446600 · Oct 1, 1996
Continuation In Part 0866754600 · Jun 21, 1996
Related Publication 20040235057A1 · Nov 25, 2004